Sygehus Lillebaelt Vejle Sygehus — Clinical Trial Site

40 Registered trials

8 Currently recruiting

Organisation

Sygehus Lillebaelt Vejle Sygehus

Location

Vejle, Denmark

Identifier

ORG-100031262

Address

Kabbeltoft 25, 7100, Denmark

Departments

4003:Onkologisk afdeling/KFE
Department of Anesthesiolgy
Department of Cardiology 76362000
Department of Hematology
Department of Medicine
Department of Medicine, Hematological Section
Department of Oncology
Department of Regional Health Research
Department of Respiratory Diseases
Dept. Of Hematology Section of Internal Medicine
Hematology
internal medicin
Lungemedicinsk Afdeling
Medical
Medical Department
N/A
Oncology
Onkologisk Afdeling
Onkologisk Afdelning
Orthopaedic Surgery

Clinical trials at this site (40)

Search interface

A Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in R/R DLBCL Ended

2023-504830-23-00 B-cell Lymphoma 5 2020-12-16
Safety and Efficacy Study of Epcoritamab in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome Ended

2023-504828-25-00 Chronic Lymphocytic Leukemia 9 2020-11-16
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) Ended

2023-504805-35-00 Lymphoma of B-cell origin 9 2020-10-22
A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Ended

2023-506365-64-00 Deleterious Germline or Somatic Homologous Recombinatio 5 2020-10-16
POLAR BEAR Ended

2022-502887-19-00 Diffuse Large B-Cell Lymphoma 5 2020-08-18
A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early… Ended

2022-501102-35-00 Early triple negative breast cancer 5 2019-12-02
An early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) Ended

2024-515690-10-00 Diffuse large B-cell lymphoma 9 2019-05-10
A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subject… Ended

2023-506112-40-00 R/R Multiple Myeloma 5 2018-09-26
A Study of Tobemstomig/RO7247669 Combined with Nab-Paclitaxel Compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with … Ended

2022-502457-34-00 Triple-Negative Breast Cancer (TNBC) 4 2024-03-13
Safety of ibuprofen after major orthopaedic surgeries Ended

2022-502502-32-00 Hip and knee arthroplasties 11 2023-04-17
Clinical trial on Spinal Anaesthesia vs. General Anaesthesia (SAGA) on recovery after hip and knee replacements Ended

2022-501221-21-00 Osteoarthritis of the hip and knee 6 2023-02-03
A study to evaluate the effects of ALIS based treatment in patients newly diagnosed with nontuberculous mycobacterial lung infection caused … Ended

2023-505273-33-00 "Adult Subjects with Newly Diagnosed Nontuberculous Myc 5 2021-02-15
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inop… Ended

2024-512331-72-00 Squamous Carcinoma of the Anal Canal 5 2020-12-22
Nivo versus Nivo/Ipi or versus other chemotherapies to treat colorectal cancer Ended

2023-503956-29-00 Microsatellite Instability High (MSI-H) or Mismatch Rep 5 2019-08-26
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Myocardinal infarction 5 2018-12-01
Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3C… Ended

2023-509167-24-00 Adult patients with PIK3CA mutant, HR-positive, HER2-ne 4 2017-10-02